We are live on ! Find out more
B

Bellecapital Portfolio holdings

AUM $625M Turnover 41.45%
1-Year Est. Return 39.69%
This Fund
S&P 500
This Quarter Est. Return
+14.21%
1 Year Est. Return
+39.69%
3 Year Est. Return
+127.77%
5 Year Est. Return
+155.51%
10 Year Est. Return
+530.96%
AUM
$157M
AUM Growth
+$16.9M
Cap. Flow
-$1.8M
Cap. Flow %
-1.15%
Top 10 Hldgs %
39.03%
Holding
125
New
21
Increased
33
Reduced
32
Closed
9
Avg Time Held
1.5 years
Top 10 Avg Time Held
1.3 years
Top 20 Avg Time Held
2.3 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 24.11%
2 Consumer Discretionary 15.84%
3 Technology 12.61%
4 Communication Services 12.05%
5 Healthcare 12.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
XLF icon
26
State Street Financial Select Sector SPDR ETF
XLF
$51.6B
$1.53M 0.97%
59,560
-15,772
-21% -$407K
2017 Q3
6 quarters
SPY icon
27
State Street SPDR S&P 500 ETF Trust
SPY
$806B
$1.31M 0.83%
4,645
– –
2015 Q4
13 quarters
MDT icon
28
Medtronic
MDT
$121B
$1.26M 0.8%
13,875
+5,717
+70% +$512K
2018 Q1
4 quarters
WFC icon
29
Wells Fargo
WFC
$252B
$1.18M 0.75%
24,367
-6,040
-20% -$297K
2016 Q2
11 quarters
MSFT icon
30
Microsoft
MSFT
$3.93T
$1.15M 0.73%
9,762
– –
2016 Q1
12 quarters
DIS icon
31
Walt Disney
DIS
$191B
$1.08M 0.69%
9,713
+7,108
+273% +$794K
2018 Q4
1 quarter
IBM icon
32
IBM
IBM
$219B
$1.01M 0.64%
7,492
+715
+11% +$91.1K
2016 Q2
11 quarters
IVV icon
33
iShares Core S&P 500 ETF
IVV
$880B
$997K 0.63%
3,502
+244
+7% +$66.7K
2018 Q3
2 quarters
BMY icon
34
Bristol-Myers Squibb
BMY
$122B
$946K 0.6%
19,833
+15,322
+340% +$763K
2018 Q4
1 quarter
IBDN icon
35
DELISTED
iShares iBonds Dec 2022 Term Corporate ETF
IBDN
$941K 0.6%
37,759
– –
2017 Q4
5 quarters
IBDL
36
DELISTED
iShares iBonds Dec 2020 Term Corporate ETF
IBDL
$935K 0.59%
37,061
– –
2017 Q4
5 quarters
K icon
37
DELISTED
Kellanova
K
$932K 0.59%
+17,298
New +$924K
2019 Q1
0 quarters
RDIV icon
38
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.45B
$909K 0.58%
24,000
– –
2017 Q3
6 quarters
BSJK
39
DELISTED
Invesco BulletShares 2020 High Yield Corporate Bond ETF
BSJK
$891K 0.57%
+37,013
New +$887K
2019 Q1
0 quarters
ZTO icon
40
ZTO Express
ZTO
$15.1B
$882K 0.56%
48,245
-16,500
-25% -$302K
2018 Q1
4 quarters
JOYY icon
41
JOYY Inc
JOYY
$4.05B
$859K 0.55%
10,221
+1,461
+17% +$106K
2018 Q3
2 quarters
TIP icon
42
iShares TIPS Bond ETF
TIP
$14.4B
$850K 0.54%
7,514
+803
+12% +$89.1K
2018 Q1
4 quarters
XOM icon
43
ExxonMobil
XOM
$736B
$824K 0.52%
10,200
– –
2013 Q4
21 quarters
MO icon
44
Altria Group
MO
$125B
$800K 0.51%
+13,931
New +$712K
2019 Q1
0 quarters
JNJ icon
45
Johnson & Johnson
JNJ
$616B
$769K 0.49%
5,499
– –
2018 Q1
4 quarters
BRK.B icon
46
Berkshire Hathaway Class B
BRK.B
$1.14T
$733K 0.47%
3,650
+927
+34% +$187K
2016 Q2
11 quarters
VLUE icon
47
iShares MSCI USA Value Factor ETF
VLUE
$9.05B
$719K 0.46%
9,000
– –
2017 Q3
6 quarters
GILD icon
48
Gilead Sciences
GILD
$194B
$716K 0.46%
+11,013
New +$732K
2019 Q1
0 quarters
BHP icon
49
BHP
BHP
$212B
$704K 0.45%
14,443
+166
+1% +$7.57K
2016 Q2
11 quarters
MPC icon
50
Marathon Petroleum
MPC
$134B
$696K 0.44%
+11,631
New +$732K
2019 Q1
0 quarters

Similar funds

Bellecapital's Q1 2019 Portfolio in Review

As of Q1 2019, Bellecapital held 125 positions worth $157M, up 12% from $140M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Bellecapital's Q1 2019 filing shows 21 new, 33 increased, 32 reduced and 9 closed positions. Its largest new stake was iShares 1-5 Year Investment Grade Corporate Bond ETF: 43,284 shares worth $2.29M. The largest sale was CVS Health, an estimated $2.24M.

By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Bellecapital's largest Q1 2019 buy was iShares 1-5 Year Investment Grade Corporate Bond ETF: 43,284 shares worth $2.29M.
  • Bellecapital added most to Walt Disney in Q1 2019, an estimated $794K increase.
  • Bellecapital's biggest Q1 2019 reduction was PRA Health Sciences, Inc., cutting an estimated $1.44M.
  • Bellecapital fully exited CVS Health in Q1 2019, selling an estimated $2.24M.
  • Bellecapital's ten largest holdings make up 39% of its $157M portfolio in Q1 2019.
  • Bellecapital opened 21 new positions and closed 9 in Q1 2019.
  • Bellecapital's portfolio value rose 12% quarter-over-quarter to $157M.

Based on Bellecapital's 13F filing for Q1 2019, filed 23 Apr 2019.